An error occurred in the article by Sharpe et al, titled “Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial,” published in the June 2020 issue of Pediatrics (2020;145[6]:e20193182; doi:10.1542/peds.2019-3182).
On page 10, the Financial Disclosure statement read: “The authors have indicated they have no financial relationships relevant to this article to disclose.” This should have read: “Drs Nespeca, Michelson, Rismanchi, and Mower and Mr Haas each declare only lunch or dinner educational interactions with UCB Pharmaceutical representatives. Mr Haas declares that he consulted for Sun Pharma Advanced Research Company Ltd after presentation of study results at the Society for Pediatric Research. Dr Wang declares clinical trial participation and service on data safety monitoring boards for Ovid Therapeutics; the other authors have indicated they have no financial relationships relevant to this article to disclose.”
The online article has been corrected.